270 likes | 421 Vues
Dr. Krisana Kraisintu's innovative approach to local antiretroviral (ARV) production in Thailand offers a cost-effective solution for HIV treatment. By manufacturing essential NRTIs and NNRTIs, such as AZT, Stavudine, and Nevirapine, the program ensures accessibility and affordability, with costs as low as $27 to $32 per person per month. This long-term strategy significantly contributes to combating HIV while addressing associated opportunistic infections. Dr. Kraisintu’s work exemplifies how local production can be a game-changer in public health.
E N D
LIFE-SAVING JOURNEY , Dr.Krisana Kraisintu Thailand
Thailand’s Experience in Local ARV production: a Long-term Solution in Implementing Successful ARV Programme
NRTIs AZT Capsule 100 mg, 300 mg AZT Syrup 10 mg/ml Didanosine (ddI) Buffered Oral Powder 30, 60, 115, 170, 230, 285 mg
NRTIs Stavudine Capsules 15, 20, 30, 40 mg Lamivudine Tablet 150 mg Syrup 10 mg/ml
NRTIs Zidovudine- Lamivudine TabletsAZT 300 mg + 3TC 150 mg NNRTIs:Nevirapine Tablet 200 mg
GPO-VIR S30 Stavudine (d4T) 30 mg Lamivudine (3TC) 150 mg Nevirapine 200 mg Cost of treatment is US$27/person/month (0.46 US$/tablet)
GPO-VIR S40 Stavudine (d4T) 40 mg Lamivudine (3TC) 150 mg Nevirapine 200 mg Cost of treatment US$ 32 /person/month ( US$ 0.54 /tablet)
Opportunistic Infections Fluconazole Capsules 100, 200 mg Ketoconazole Tablets 200 mg Clarithromycin Tablets 250, 500 mg Clarithromycin Dry Suspension Rifampicin Capsules 300, 450 mg INH Tablets 100 mg Ethambutol Tablets 250, 400 mg Co-trimoxazole Tablets